Dissanaike Sharmila 4/A
4/A · HERON THERAPEUTICS, INC. /DE/ · Filed Feb 4, 2025
Insider Transaction Report
Form 4/AAmended
Dissanaike Sharmila
Director
Transactions
- Award
Common Stock
2025-01-31+17,950→ 87,180 total - Award
Stock Option (Right to Buy)
2025-01-31+35,900→ 35,900 totalExercise: $1.70Exp: 2035-01-31→ Common Stock (35,900 underlying)
Footnotes (2)
- [F1]The shares were granted as restricted stock units which vest in full on January 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.